The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2023
Filed:
Apr. 17, 2014
Applicants:
Samjin Pharmaceutical Co., Ltd., Seoul, KR;
Astech. Co., Ltd., Suwon-si, KR;
Inventors:
Eui Hwan Cho, Seoul, KR;
Sung Ju Choi, Seoul, KR;
Sung Woo Lee, Seoul, KR;
Hee Jong Shin, Bucheon-si, KR;
Jong Bae Yoon, Suwon-si, KR;
Ki Seok Park, Siheung-si, KR;
Ho Tae Nam, Suwon-si, KR;
Assignees:
SAMJIN PHARMACEUTICAL CO., LTD., Seoul, KR;
ASTECH. CO., LTD., Gyeonggi-Do, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/4704 (2006.01); A61P 27/00 (2006.01); A61K 31/4725 (2006.01); A61K 9/00 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0053 (2013.01); A61K 31/4704 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01);
Abstract
Disclosed is an oral pharmaceutical composition for preventing or treating dry eye syndrome, which comprises rebamipide or a prodrug thereof, or a pharmaceutically acceptable salt thereof, as an active ingredient. The compounds can treat dry eye syndrome via oral route, and can be thus employed safely and conveniently compared to conventional eye drops.